April 2009 Volume 5, Issue 4

Volume 5, Issue 4 | April 2009

April 2009

In this Issue

Research & Development

Drug Discovery News Placeholder Image

Merck, Schering merge in $41.1B deal

Increasing generic competition and pricing pressures unite two more of the world's largest pharmas
Drug Discovery News Placeholder Image

Obama brings change to stem cell arena

Industry reacts to executive order lifting federal funding restrictions on embryonic stem cell research
Drug Discovery News Placeholder Image

Gilead’s $1.4B bid wins nod from CVT’s board

Astellas' three offers fail to entice CV Therapeutics
Drug Discovery News Placeholder Image

Genentech, Salk find new mechanism that may lead to Alzheimer's disease

The mechanism of action of a heretofore puzzling protein thought to play a key role in Alzheimer's disease has been unraveled by scientists at Genentech and the Salk Institute.
Drug Discovery News Placeholder Image

Putting liver on a chip

Battelle Ventures spins out Hepregen, commits $5 million to develop microliver platform.
Drug Discovery News Placeholder Image

Researchers close in on possible flu foe

Scientists identify human monoclonal antibodies to fight bird and seasonal flu viruses.
Drug Discovery News Placeholder Image

U.S. lawmakers revisit plans to approve biosimilars

Congressional lawmakers recently introduced two competing bills that would create an approval process for generic biopharmaceuticals.

Global News

Drug Discovery News Placeholder Image

All pharma friends again

After an initial tender offer, two refusals and a hostile takeover threat, Roche finds a price that Genentech likes
Drug Discovery News Placeholder Image

Talkin' 'bout regeneration

Novartis and Epistem have inked a regenerative medicine R&D deal worth up to $50 million.
Drug Discovery News Placeholder Image

Cancer’s silver bullet

UK’s Argenta Discovery and PRECOS have launched a cancer drug discovery alliance.
Drug Discovery News Placeholder Image

Lean on me

Pharmexa and Affitech are looking to reverse merger deal to get them back on track in the antibody field.
Drug Discovery News Placeholder Image

Buy and build

Lab21 eyes international growth with Biotec Laboratories acquisition.

Editor's Focus

Drug Discovery News Placeholder Image

Stop the presses: DDN expands online product

As other publishers are finding ways to cut their services, DDN is growing and becoming more innovative in the way we reach our readers, while still maintaining our dedication to excellent news reporting. Effective this month, you will notice that we have made many changes to DDN Online and drugdiscoverynews.com to respond to our readers’ changing needs and habits.

Commentary

Drug Discovery News Placeholder Image

Patent Office budget shortfall will have long-term effects

You’re not alone in your financial suffering. The recession has even hit the U.S. Patent and Trademark Office, which is funded by fees paid by applicants for patent applications and other services.
Drug Discovery News Placeholder Image

Stem cell controversy continues

Despite lifted federal funding ban, new research methods and FDA approvals, social and ethical questions remain

Automation & Instrumentation

Drug Discovery News Placeholder Image

Closing the gaps

Beckman Coulter acquires Olympus' Life Science business and gains comprehensive range of diagnostic capabilities.
Drug Discovery News Placeholder Image

Millipore acquires Epitome’s EpiTag assets

Acquisition will accelerate the development of multiplex immunoassays for cell signaling.
Drug Discovery News Placeholder Image

Time-to-clinic tools

GE Healthcare and Tecan will team up to streamline process development.
Drug Discovery News Placeholder Image

Bedside to bench

Gentel and Eprogen commercialize whole-proteome array technology
Drug Discovery News Placeholder Image

DDN Editorial Roundtable: Current and Emerging Trends in Automation and Detection

At ALA's LabAutomation2009, Drug Discovery News assembled an expert panel to discuss assay automation--about how their operations run, as well as some of the hurdles they face in automating assays.

Genomics & Proteomics

Drug Discovery News Placeholder Image

Getting the signals crossed

A collaboration between Imperial College and GSK focused on mRNA suggests signaling problems in the brain may lead to schizophrenia.
Drug Discovery News Placeholder Image

Genome sequencing for $5,000?

Complete Genomics is partnering with Broad Institute to conduct human sequencing studies of cancer.
Drug Discovery News Placeholder Image

HIV primate progress

Researchers at Rockefeller University have successfully altered one gene in HIV-1 to infect monkeys with a human version of virus.
Drug Discovery News Placeholder Image

Mighty ‘mito’

University of Virginia researchers may have identified a key to reversing neurodegenerative disease in investigational protein.
Drug Discovery News Placeholder Image

Clearing the air(way) in fight against CF

Researchers find that IFRD1 gene might be a key to treating cystic fibrosis lung disease.

Informatics

Drug Discovery News Placeholder Image

Breaking down silos

Waters and LabVantage integrate laboratory informatics to advance data management across global organizations.
Drug Discovery News Placeholder Image

Deliver the liver

Entelos, the Hamner Institutes and FDA team up to create in silico platform for liver toxicity.
Drug Discovery News Placeholder Image

‘Parallelized’ next-gen sequencing database

National Center for Genome Resources chooses Kognitio WX2 database to peer more deeply into the genome for next-gen sequencing data.
Drug Discovery News Placeholder Image

The dawn of collaborative research

Arizona Biomedical Research Commission strikes deal with 5AM Solutions to develop virtual tissue bank serving bioresearchers
Drug Discovery News Placeholder Image

Cystic fibrosis research goes electronic

Cystic Fibrosis Foundation deploys Medidata Solutions’ Rave platform to manage clinical data, increase efficiency
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue